Combinostics

Wow, what an incredible time we had at this year's RSNA conference in Chicago! It was fantastic to reconnect with familiar faces and meet new ones too.

If you couldn't make it to the conference, fret not! We've got you covered. 🙌🎉 Reach out to us and schedule a personalized demo to experience the groundbreaking solutions we showcased at RSNA.

📞🗓️ Contact us now to secure your spot: https://eu1.hubs.ly/H06sgY10

It's the final day of , so don't miss the opportunity to stop by the Combinostics' booth 3971 in the AI Showcase to discover more about our cloud-based platform delivering AI solutions like cMRI™, cDSI™, and cPET™.

But that's not all! At 3:00 - 3:30pm CT, join us at the deepc booth #4578 for a presentation by Hans-Peter Huber exploring MRI quantification for Neurological Disorders.

So, what are you waiting for? Make your way to the Combinostics' booth and deepc booth today.

Join us tomorrow for the AI in Action presentation at the deepc booth #4578, where Combinostics' VP of European Sales Hans-Peter Huber will discuss MRI quantification for neurological disorders. 🧠✨

📅 Mark your calendars for November 29th from 3:00 - 3:30pm CT.

We can't wait to see you there! 🙌

Combinostics is pleased to announce that our new PET quantification application, cNeuro cPET, has received FDA 510(k) clearance and is now available in the United States.

cPET's unique image registration technique allows for increased accuracy and confidence in the quantification of FDG and amyloid PET scans.

cPET offers both a PET-only and a PET-MRI workflow, and if the patient's MRI is available, the integration with Combinostics cMRI enhances the quantification of brain regions, including small structures such as the hippocampus.

🧠📊 Are you a radiologist or clinician looking to enhance your assessment of neurological disorders?

With specialty reports tailored for multiple conditions including MS, Epilepsy, TBI, and Dementia, Combinostics cMRI provides invaluable insights for accurate diagnosis and effective treatment planning. 🏥💡

Click the link below to watch a video and discover more about each report. 👇

📺 Video: https://eu1.hubs.ly/H05jmmr0

Our cPET Amyloid report brings a new level of objectivity to borderline cases. Here's what it offers:

✅ Quality Control (QC) information - including image planes, tracer name, injected activity, and selected reference region.

✅ 3D SSP images - Our report highlights areas where tracer uptake deviates from reference data, ensuring accurate analysis with a 2 SD threshold applied.

✅ SUVRs and z-scores - We provide comprehensive data for target regions, a cortical composite region, and reference regions.

✅ Centiloid scale - Tracer uptake in the cortical composite region is presented in this standardized scale, allowing for easy comparison and interpretation.

📚 Curious to learn more? Click here to dive into our report interpretation: https://eu1.hubs.ly/H052Qr20